Glycopeptide-based Compounds for Agricultural, Food, Environmental, and Medical Applications

Publication ID: 24-11857597_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Glycopeptide-based Compounds for Agricultural, Food, Environmental, and Medical Applications,” Published Technical Disclosure No. 24-11857597_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857597_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,597.

Summary of the Inventive Concept

The inventive concept leverages the core technology of lipo-glycopeptide cleavable derivatives to address various unmet needs in agricultural, food, environmental, and medical industries, providing novel solutions for disease prevention, food preservation, bioremediation, and medical device protection.

Background and Problem Solved

The original patent disclosed lipo-glycopeptide cleavable derivatives for treating Gram-positive bacterial infections. However, there is a growing need for innovative solutions in other industries, such as agriculture, food, environmental, and medical, to address pressing challenges like crop diseases, food spoilage, soil pollution, and medical device contamination. The new inventive concept addresses these limitations by applying the core technology to these new fields.

Detailed Description of the Inventive Concept

The inventive concept comprises glycopeptide-based compounds that are cleavable by enzymatic hydrolysis, which can be applied to various industries. In agriculture, the compounds can be used to detect and prevent crop diseases. In food preservation, the compounds inhibit bacterial and fungal growth, extending shelf life. In environmental remediation, the compounds break down pollutants in contaminated soil. In medical applications, the compounds treat bacterial diseases in aquatic life and prevent biofilm formation on medical devices. These compounds offer a versatile solution for diverse industries.

Novelty and Inventive Step

The new inventive concept introduces novel applications and use cases for the lipo-glycopeptide cleavable derivatives, which were not contemplated in the original patent. The inventive step lies in recognizing the potential of these compounds to address unmet needs in various industries, beyond their original purpose.

Alternative Embodiments and Variations

Alternative embodiments may include modifications to the glycopeptide-based compounds, such as varying the type of enzymatic hydrolysis or the specific industries in which they are applied. Variations may also include combining these compounds with other technologies, like nanotechnology or biotechnology, to enhance their effectiveness.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, food processing, environmental remediation, and medical devices. The market size is substantial, with opportunities for partnerships, licensing, and product development.

CPC Classifications

SectionClassGroup
A A61 A61K38/14
A A61 A61K9/008
A A61 A61K9/0073
A A61 A61K9/0075
A A61 A61P31/04

Field of Art

Pharmaceutical and biotechnology research, specifically focused on antimicrobial compounds, drug delivery systems, and enzymatic treatments for bacterial infections across medical, agricultural, and environmental applications

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degrees in microbiology, biochemistry, or pharmaceutical sciences, possessing expertise in compound design, enzymatic interactions, and interdisciplinary applications of antimicrobial technologies

Obviousness Rationale

A person of ordinary skill would recognize the inherent versatility of lipo-glycopeptide cleavable derivatives and find it obvious to extend their application beyond the original medical context to agricultural, environmental, and food preservation domains. The fundamental mechanism of enzymatic cleavage and antibacterial properties provides a predictable basis for exploring alternative use cases. The PTD represents a straightforward extrapolation of the source patent's core technological principles.

Obvious Combinations & Variations

Source Patent Element
Method of treating Gram-positive bacterial infections via targeted drug delivery
PTD Variation
Applying glycopeptide compounds to prevent crop fungal infections
Obviousness Reasoning
Known technique of leveraging antimicrobial properties across biological systems, with predictable results in disease prevention
Source Patent Element
Nebulizer and dry powder inhaler delivery mechanisms
PTD Variation
Applying compounds through alternative delivery methods in agriculture and environmental remediation
Obviousness Reasoning
Routine engineering adaptation of drug delivery technologies to different application contexts
Source Patent Element
Enzymatic cleavage mechanism for targeting bacterial infections
PTD Variation
Using enzymatic hydrolysis to break down environmental pollutants and prevent biofilm formation
Obviousness Reasoning
Predictable extension of known enzymatic interaction principles to solve related technical problems
Source Patent Element
Targeting specific bacterial strains like Staphylococcus and Enterococcus
PTD Variation
Broadening compound applications to multiple industries with similar bacterial interaction mechanisms
Obviousness Reasoning
Logical progression of understanding compound's fundamental interaction with biological systems
Source Patent Element
Pharmaceutical composition for treating pulmonary bacterial infections
PTD Variation
Developing multi-industry applications including food preservation and aquatic disease treatment
Obviousness Reasoning
Obvious exploration of compound's inherent antimicrobial properties across different technological domains
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857597, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure obvious, as the core technological principles of lipo-glycopeptide cleavable derivatives demonstrate predictable and extensible applications across multiple technical domains. The disclosed variations represent routine engineering adaptations and logical extrapolations of the source patent's fundamental antimicrobial compound technology.

Original Patent Information

Patent NumberUS 11,857,597
TitleLipo-glycopeptide cleavable derivatives and uses thereof
Assignee(s)Insmed Incorporated